Table 2B. (B) Microsatellite unstable (MSI) proximal colon cancer.
Overall survival |
Recurrence-free survival |
|||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
APC-wt v APC-mt | 0.90 (0.27–2.96) | 0.859 | 1.26 (0.25–6.50) | 0.779 |
Age (Decades) | 2.37 (1.30–4.34) | 0.005* | 0.95 (0.40–2.25) | 0.900 |
Gender (Female vs Male) | 1.06 (0.31–3.59) | 0.924 | 1.58 (0.32–7.80) | 0.576 |
Stage III vs I/IIa | 0.95 (0.31–2.90) | 0.933 | 3.36 (0.62–18.30) | 0.161 |
Stage IV vs I/IIa | 5.54 (0.38–81.75) | 0.213 | ||
Chemotherapy (Yes vs No) | 2.10 (0.47–9.37) | 0.330 | 0.25 (0.03–1.99) | 0.189 |
Events/N | 17/75 | 9/53 |
Abbreviations: CI=confidence interval; Dist=distal; HR=hazard ratio.
Combined stages I/II referent owing to small sample number. *P<0.05.